ArticleBMC cancer2023

BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells.

Yaya Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.